Top Official Discusses Resignation From Brazil’s ANVISA Over Patent Policy 11/08/2011 by William New, Intellectual Property Watch 1 Comment Luis Carlos Wanderly Lima, a senior official responsible for Brazil’s policy of giving a voice to its health ministry in the examination of patent applications with potential impact on public health, recently resigned in protest about changes to the policy. In a Q&A with Intellectual Property Watch, he discussed his decision.
Promoting Caribbean Intellectual Property Law 08/08/2011 by Intellectual Property Watch 1 Comment Across the world, the Caribbean is renowned for its unique flavors in music and entertainment, its beaches, cricket, and its commonly acclaimed fun and sun. While these are well-deserved, and are sources of just pride, this common perception provides foliage which bars the examination and explanation of the real problems and needs in intellectual property in the Caribbean, writes attorney Abiola Inniss.
Getting The Most Value From Your Patent Claims 04/08/2011 by Intellectual Property Watch 2 Comments Preparing patents is both a science and an art. The science is often easy to recognize, if not always easy to understand. The art of properly expressing that science in the words of a patent claim is harder to evaluate and is more often overlooked, yet is crucial to the value of the patent, write Heather J. DiPietrantonio and Edmund J. Walsh.
A Glance At Current Patent Litigation In India 29/07/2011 by Intellectual Property Watch Leave a Comment The third amendment of Patents Act 1970, in 2005, was a major breakthrough for Indian IP practice in patents. The current crop of judicial decisions, discussed in this note, has initiated the need to have a critical mass of judicial precedents streamlining law and rules governing patent practice in India, writes Kamakhya Srivastava.
Corporate Self-Interest And Strategic Choices: Gilead Licenses To Medicines Patent Pool 21/07/2011 by Intellectual Property Watch 3 Comments Gilead’s recently announced ARV licenses to the Medicines Patent Pool, although positive in some respects, still unreasonably limit the geographical access of key middle-income countries and restrict the sourcing of APIs and products to Indian companies, meaning that both generics companies and excluded countries will need to make strategic decisions to bypass the defects in the licenses, writes Brook Baker.
Interview With Chief Judge Paul R. Michel On US Patent Reform 14/07/2011 by Intellectual Property Watch 7 Comments Chief Judge Paul R. Michel (Ret.), of the U.S. Court of Appeals for the Federal Circuit, saw hundreds of patent cases during his distinguished career and has a unique position from which to view and offer advice on efforts in the US Senate and House of Representatives to agree on changes to domestic patent law. Intellectual Property Watch recently had the opportunity to interview Judge Michel on prospects for substantive patent reform in the US, the effect on future cases involving domestic and foreign patents, likely constitutional challenges, and the “non-problem” of non-practicing entities.
Does Introduction Of A Utility Model Protection Regime Make Sense In India? 13/07/2011 by Intellectual Property Watch 2 Comments India has at least seven diverse intellectual property (IP) legislations related to protection already in place. Its focus should therefore arguably be directed – along the lines of many other IP jurisdictions – on more stringent enforcement modus operandi of the IP rights. Is there scope for introducing yet another IP legislation – the utility model protection law – in the Indian IP landscape and if so, what should be its scope and implication, asks Swarup Kumar.
Trans-Pacific Partnership Agreement: Did US Move Threaten Public Health? 12/07/2011 by Catherine Saez, Intellectual Property Watch 3 Comments Civil society groups say a leaked document from regional free trade negotiations between countries bordering the Pacific Ocean shows the United States favouring giant pharmaceutical companies at the expense of public health. Separately, the tobacco industry is allegedly also trying to push for a clause to prevent plain packaging.
Non-Communicable Diseases Issue Energises Public Health Policymakers 07/07/2011 by William New, Intellectual Property Watch Leave a Comment Concern over non-communicable diseases – traditionally a more developed-country set of problems like diabetes – is energising the international public health policy community. But representatives of the public interest are still grappling with their response.
WIPO Panel Weighs Role Of Internet Intermediaries In Online Copyright Infringement 01/07/2011 by Catherine Saez, Intellectual Property Watch Leave a Comment The role and responsibility of internet intermediaries in the protection of copyright is under debate in several policy fora and often brings up issues such as privacy, access to knowledge, and freedom of expression. A panel was organised last week at the World Intellectual Property Organization to explore the viewpoints of several but not all stakeholders on this issue.